pros and cons of glp 1 The Benefits GLP-1 Therapy: Beyond Weight Loss glp 1 used for weight
Description
Retatrutide , a triple-agonist targeting GLP-1, GIP, and glucagon receptors simultaneously, has shown weight loss results exceeding those of current dual-agonists

The United States accounts for approximately 40% of global GLP-1 use, though adoption is accelerating in Europe, Australia, and other developed markets as awareness and reimbursement expand
The liver enzyme pattern is noteworthy because retatrutide simultaneously shows potent fat-clearing effects in the liver (beneficial for MASLD/NAFLD) while occasionally triggering transient enzyme elevations

Follow-up: What does follow-up care look like

Diabetes Care 43, 10851093

And despite recent reports of a potential federal pilot program to extend coverage of GLP-1 obesity drugs under Medicaid and Medicare, all state Medicaid programs are likely to be under pressure due to steep spending cuts in the budget reconciliation package recently signed into law by President Donald Trump
